Skip to main content
. 2020 Mar 17;2(1):123–126. doi: 10.1016/j.jaccao.2019.12.001

Figure 2.

Figure 2

Nilotinib Enhanced Valvular Interstitial Cell Calcification and Osteogenic Signaling

Treatment of human valvular interstitial cells with nilotinib increased phosphate-induced calcification after 9 days and mRNA expression of the osteogenic activator bone morphogenic protein (BMP)-2 after 24 h. In contrast, treatment with imatinib was not significantly different from vehicle control (dimethyl sulfoxide). Data represented as mean ± SD. **p < 0.01; ***p < 0.001.